Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

1,406 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 298
Recruiting: 143
Ph III recruiting: 19
Growth YoY: −14%
Industry share: 35%
Top sponsor: City of Hope Medical Center
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (273)

clinicaltrialsPublishedShowing 301–350 of 1,406 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02158091	A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL	active not recruiting	Phase 1 / Phase 2	32	Dana-Farber Cancer InstituteOTHER	1	Feb 13, 2026	clinicaltrials
NCT03580928	Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL(AVO)	active not recruiting	Phase 2	72	Dana-Farber Cancer InstituteOTHER	1	Feb 13, 2026	clinicaltrials